(Q50592202)

16 March 2018

title

Comparative in vitro studies of Tiazofurin and a selenazole analog. (English)

1 reference

16 March 2018

author name string

D G Streeter

series ordinal

1

1 reference

16 March 2018

R K Robins

series ordinal

2

1 reference

16 March 2018

language of work or name

English

0 references

publication date

1 September 1983

1 reference

16 March 2018

Biochemical and Biophysical Research Communications

published in

1 reference

16 March 2018

volume

115

1 reference

16 March 2018

issue

2

1 reference

16 March 2018

page(s)

544-550

1 reference

16 March 2018

Synthesis and antiviral activity of certain thiazole C-nucleosides

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2883%2980179-X

2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2883%2980179-X

Initial studies on the mechanism of action of a new oncolytic thiazole nucleoside, 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2883%2980179-X

Mechanism of resistance to the oncolytic C-nucleoside 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC-286193).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2883%2980179-X

Studies on the mechanism of action of 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193)--II. Relationship between dose level and biochemical effects in P388 leukemia in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2883%2980179-X

The invitro inhibition of purine nucleotide biosynthesis by 2-β-D-ribofuranosylthiazole-4-carboxamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2883%2980179-X

Inhibition of inosinate dehydrogenase by metabolites of 2-beta-D-ribofuranosyl thiazole-4-carboxamide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2883%2980179-X

The conversion of 2-β-D-ribofuranosylthiazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2883%2980179-X

Synthesis and antitumor activity of 2-beta-D-ribofuranosylselenazole-4- carboxamide and related derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2883%2980179-X

Inhibition of purine metabolism—Computer- assisted analysis of drug effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2883%2980179-X

10.1016/S0006-291X(83)80179-X

7 January 2021

Identifiers

DOI

1 reference

16 March 2018

1 reference

16 March 2018